Illustrative image – not actual.
The Competition Commission of India (CCI) has approved detergent-to-cement conglomerate Nirma's acquisition of a majority stake in Glenmark Life Sciences (GLS).
Nirma in September, 2023 had agreed to acquire 75 percent of GLS for Rs 5,651.5 crore, marking the company's significant push into the pharmaceutical sector.
GLS is engaged in the manufacture and sale of active pharmaceutical ingredients (APIs) and contract development and manufacturing organisation (CDMO) services. The Ahmedabad-based company is a diversified manufacturer of chemicals such as soda ash, caustic soda, detergents and edible salt.
